close

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It provides patients and physicians the access to diagnostic laboratory services through its network of laboratories and owned patient service centers; and interpretive consultation. The company also offers commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, microbiology testing, alcohol and other substance-abuse tests, and allergy tests; cancer diagnostics, such as anatomic pathology services; and gene-based and other esoteric testing. In addition, it offers various risk assessment services for insurance companies. Further, Quest Diagnostics develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of Herpes Simplex virus and are sold to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer, a whole-blood test performed on finger-stick samples for providing a total white blood cell count; and InSure fecal immunochemical test for screening for colorectal cancer. Additionally, it develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; offers the ChartMaxx electronic document management system for hospitals; and has capabilities to deploy a health information exchange system enabling healthcare providers to access and manage patient data from multiple sources at the point-of-care. Quest Diagnostics also collaborates with Google to launch Google Health that allows patients to share, save, organize, and manage their medical records and personal health information online. The company was founded in 1967 and is headquartered in Madison, New Jersey.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	59.27
Volume	716184
Volume Avg	(mio) 1.05
52 Week High	61.47
52 Week Low	45.13
PE	20.12
PE (group average)	39
EPS Year	2.92
EPS change Q/Q	1000%
EPS change Q/Q Yr ago	1000%
EPS change Q/Q next Q est	1000%
EPS change Y/Y	37.06%
REV change Q/Q	0%
REV change Q/Q Yr ago	0%
EPS next Q est	1.17
EPS next Y est	5.05
Divident Annual	0.47
Dividend Yield	0.79%